Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about psilocybin therapy

Recent news which mentions psilocybin therapy

Kaya Holdings Advocates For Psilocybin As FDA Rejects MDMA For PTSD Treatment
Tickers KAYS NEWS
Tags Cannabis Kaya Holdings Market News
From Benzinga
Utah Hospitals Will Soon Provide Psilocybin And MDMA Therapy For Mental Health Conditions
Tickers NEWS NUMIF
Tags News NUMIF Cannabis
From Benzinga
Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More
Tickers ATAI CMND CMPS CYBN
Tags MNMD Benzinga HUGE
From Benzinga
Washington Doctor Vs. DEA For Lawful Use Of Psilocybin To Treat Terminally Ill Patients
Tickers NEWS
Tags right/to/try laws News Benzinga
From Benzinga
Canadian At-Home Microdose Psilocybin Clinical Trial Finalized, Here Are The Details
Tags Apex Labs Market News psilocybin therapy
From Benzinga
Meth Use Disorder Tackled With Psilocybin: Clinical Trial Begins Patient Enrollment
Tickers RVVTF
Tags News RVVTF Psychedelics
From Benzinga
Canada's Ongoing Struggle For Access To Natural Psilocybin As A Therapeutic Nabs Business Support
Tickers TRUFF
Tags TheraPsil Markets Market News
From Benzinga
Canadian Psychedelics Company Launches Take-Home Psilocybin Trial For Some 300 Participants
Tags News Cannabis Market News
From Benzinga
Virginia Psychedelics: Legalizing Medical Use Of Psilocybin Gets A Thumbs Down
Tags Psychedelics Legalization News Psychedelics
From Benzinga
2023 Could Be Make Or Break For Psychedelics In Missouri, This GOP Lawmaker Is Pushing For Change
Tags Missouri Rep/ Tony Lovasco Legal
From Benzinga
What Happened With Psychedelics In The Last Year? 11 Key News Items, The Sector's Performance & Takeaways
Tickers ATAI AWKNF CMND CMPS
Tags Cannabis Drug Enforcement Administration SILO
From Benzinga
Oregon's Final Rules For Psilocybin Services Are Ready, Learn What To Expect
Tags Psychedelics Benzinga Regulations
From Benzinga
First-Ever Clinical Trial On Magic Mushroom Therapy For Autism's Genetic Cause Receives Approval
Tickers KONEF NMLSF
Tags Penny Stocks Health Canada Approval clinical trial
From Benzinga
Canada: Fed Guidelines For Psychedelic Therapy, Quebec Treatment Costs, Access And Magic Mushrooms Dispensaries
Tags News Benzinga Psychedelics
From Benzinga
Potential Road To At-Home Psychedelics Use Permits: Low Dosing's Positive Outcomes In Phase 1 Trial
Tags Markets Market News psilocybin therapy
From Benzinga
Magic Mushrooms Tested For Treating Type II Bipolar Disorder, Check Out Results So Far
Tickers CMPS
Tags News Markets Cannabis
From Benzinga
DEA's Consistent Denial Of Psilocybin Access For Terminally Ill Being Challenged Again
Tickers CSA DEA
Tags Legal Dr/ Sunil Aggarwal RTT
From Benzinga
In Oregon You Can Get Trained To Be A Licensed Psilocybin Therapy Provider
Tags Markets Measure 109 Market News
From Benzinga
Cannabis & Psychedelics As Effective Adjunct Medicine To Breast Cancer Therapy? Studies Say Yes
Tags Health Care News Cannabis
From Benzinga
Why Magic Mushrooms Are Emerging As Major Part Of Public Discourse: What Science Is Saying
Tickers CMPS
Tags psilocybin therapy smoking cessation CMPS
From Benzinga
Why Magic Mushrooms Are Emerging As Major Part Of Public Discourse: The Legal Situation
Tags Cannabis psilocybin therapy Market News
From Benzinga
Major Psychedelics Firm Is Studying Magic Mushrooms To Treat Meth Addiction
Tickers RVVTF
Tags University of Wisconsin RVVTF Psychedelics
From Benzinga
Mindset Pharma Meets With UK Regulator: Is A Phase 1 Trial Getting Close?
Tickers MSSTF
Tags Global major depressive disorder James Lanthier
From Benzinga
Psychedelics Companies Are Teaming Up To Offer Access Veterans
Tickers AWKNF RVLWF
Tags Global Contracts Market News
From Benzinga
Cathie Wood's Psychedelics Fund ARK Analyzes The Sector's Present & Future And Likes What It Sees
Tickers ATAI
Tags US Healthcare System Markets Cathie Wood
From Benzinga
Study Finds Psilocybin Anti-Depression Effects Last At Least One Year
Tags psychedelics Benzinga contributors
From Benzinga
The Case For Psilocybin Therapy And Depression
Tags Markets Psilocybin Market News
From Benzinga
ATAI Life Sciences Announces New Program To Discover Next-Generation Mental Health Treatments
Tickers ATAI
Tags Biotech Benzinga PTSD
From Benzinga
Psilocybin Therapy Combined With SSRI Antidepressants Is Possible, COMPASS Study Confirms
Tickers CMPS
Tags News Market News Cannabis
From Benzinga
Peter Thiel-Backed Psychedelic Start-Up, ATAI Life Sciences, Increases Stake In Compass Pathways
Tickers ATAI CMPS
Tags Government ATAI Life Sciences Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.